Ito, Mamoru
Okumura, Yuta
Nio, Kenta
Baba, Eishi
Ozaki, Yukinori
Nishio, Hiroshi
Ichihara, Eiki
Miura, Yuji
Endo, Makoto
Yano, Shingo
Maruyama, Dai
Yoshinami, Tetsuhiro
Susumu, Nobuyuki
Takekuma, Munetaka
Motohashi, Takashi
Ochi, Nobuaki
Kubo, Toshio
Uchino, Keita
Kimura, Takahiro
Kamiyama, Yutaro
Nakao, Shinji
Tamura, Shinobu
Nishimoto, Hitomi
Kato, Yasuhisa
Sato, Atsushi
Takano, Toshimi
Tsuchihashi, Kenji http://orcid.org/0000-0002-9014-6382
Article History
Received: 30 January 2024
Accepted: 4 March 2024
First Online: 5 April 2024
Declarations
:
: Eishi Baba received honoraria from Chugai Pharmaceutical Co., Ltd. and Daiichi Sankyo Co., Ltd., and research funding from Taiho Pharmaceutical Co., Ltd. and Chugai Pharmaceutical Co., Ltd. Yukinori Ozaki received honoraria from Daiichi Sankyo Co., Ltd., Pfizer Japan Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., and Kyowa Kirin Co., Ltd. Eiki Ichihara received honoraria from Eli Lilly Japan K.K. and research funding from MSD K.K., Ono Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., and Takeda Pharmaceutical Co., Ltd. Yuji Miura received honoraria from Ono Pharmaceutical Co., Ltd., MSD K.K., Takeda Pharmaceutical Co., Ltd., Eisai Co., Ltd., and Bristol Myers Squibb Co., Ltd., and research funding from MSD K.K. and Ono Pharmaceutical Co., Ltd. Shingo Yano received research funding from Otsuka Pharmaceutical Co., Ltd. Dai Maruyama received honoraria from Ono Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Nippon Shinyaku Co., Ltd., Eisai Co., Ltd., Mundipharma, Kyowa Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Zenyaku Holdings Co., Ltd., MSD K.K., SymBio Pharmaceutical Ltd., Sanofi K.K., AbbVie Inc., Takeda Pharmaceutical Co., Ltd., AstraZeneca K.K., Bristol Myers Squibb Co., Ltd., and Genmab K.K., and research funding from Amgen K.K., Astellas Pharma Inc., Biopharma Co., Ltd., Novartis Pharmaceutical K.K., Kyowa Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., Bristol Myers Squibb Co., Ltd., AbbVie Inc., Eisai Co., Ltd., MSD K.K., Taiho Pharmaceutical Co., Ltd., AstraZeneca K.K., Eli Lilly Japan K.K., and Genmab K.K. Tetsuhiro Yoshinami received honoraria from Kyowa Kirin Co., Ltd., Pfizer Japan Inc., Chugai Pharmaceutical Co., Eli Lilly Japan K.K., MSD K.K., AstraZeneca K.K., and Eisai Co., Ltd. Takashi Motohashi received honoraria from AstraZeneca K. K., Chugai Pharmaceutical Co., and Myriad Genetics G. K. Toshio Kubo has received honoraria from Chugai Pharmaceutical Co. Takahiro Kimura received honoraria from Sanofi K.K. Shinji Nakao received honoraria from Kyowa Kirin Co., Ltd. Atsushi Sato received honoraria from Chugai Pharmaceutical Co., and Taiho Pharmaceutical Co., Ltd., and received scholarship donations from Chugai Pharmaceutical Co., and Taiho Pharmaceutical Co., Ltd. Toshimi Takano received honoraria from Daiichi Sankyo Co., Ltd., Chugai Pharmaceutical Co., and Eli Lilly Japan K.K. Kenji Tsuchihashi received honoraria from Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Taiho Pharmaceutical Co., Ltd., and Novartis Pharmaceutical K.K.